State of Type 1 Diabetes Care in the United States in 2016–2018 from T1D Exchange Registry Data

I n this issue of Diabetes Therapeutics , Foster et al. provide a superb and timely analysis of the current state of treatment of people with type 1 diabetes (T1D) in the United States in the years 2016–2018 using extensive data from the T1D Exchange Registry. 1 This study is a follow-up to an analysis by Miller et al., utilizing a similar source of data for 2010–2012. 2 This analysis of a rich data set for 22,697 individuals from 81 pediatric and adult endocrinology clinics and practices in the United States provides an update on progress and obstacles facing the entire diabetes community. 1